Ndemicity in 2010. PLoS Negl Trop Dis 2012, six:e1814. 2. Tijtra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, Lampah DA, Value RN: Multidrug-resistant Plasmodium vivax associated with extreme and fatal malaria: a prospective study in Papua. Indonesia PLoS Med 2008, five:e128. 3. Lomar AV, Vidal JE, Lomar FP, Barbas CV, Matos GJ, Boulos M: Acute respiratory distress syndrome resulting from vivax malaria: case report and literature assessment. Braz J Infect Dis 2005, 9:425?30. 4. Oliveira-Ferreira J, Lacerda MVG, Brasil P, Ladislau JLB, Tauil PL, Daniel-Ribeiro CT: Malaria in Brazil: an overview. Malar J 2010, 9:1?five. five. Santos-Cimiera PD, Roberts DR, Alecrim MGC, Costa MR, Quinnan GV: Malaria diagnosis and hospitalization trends. Emerg Infect Dis 2007, 13:1597?600. 6. Ramos Junior WM, Sardinha JF, Costa MR, Santana VS, Alecrim MGC, Lacerda MV: Clinical aspects of hemolysis in sufferers with P.vivax malaria treated with primaquine, within the Brazilian Amazon. Braz J Infect Dis 2010, 14:410?12.Fabbri et al. Malaria Journal 2013, 12:315 http://malariajournal/content/12/1/Page 7 of7.8.9.ten. 11. 12. 13. 14.15. 16.17.18. 19.20. 21.22.23. 24.25.26. 27.28. 29. 30.31. 32.Sarkar D, Ray S, Saha M, Chakraborty A, Talukdar A: Clinico-laboratory profile of extreme Plasmodium vivax malaria inside a tertiary care centre in Kolkata.3-Methylcyclopentane-1-carboxylic acid Order Trop Parasitol 2013, 3:53?7. Alexandre MA, Ferreira CO, Siqueira AM, Magalhaes BL, Mourao MPG, Lacerda MVG, Alecrim MGC: Severe Plasmodium vivax malaria, Brazilian Amazon. Emerg Infect Dis 2010, 16:1611?614. Kochar DK, Das A, Kochar SK, Saxena V, Sirohi P, Garg S, Kochar A, Khatri MP, Gupta V: Extreme Plasmodium vivax malaria: a report on serial situations from Bikaner in northwestern India.Tachysterol 3 supplier Am J Trop Med Hyg 2009, 80:194?98. Kochar DK, Saxena V, Singh N, Kochar SK, Kumar SV, Das A: Plasmodium vivax malaria. Emerg Infect Dis 2005, 11:132?34. WHO: Extreme falciparum malaria. Trans R Soc Trop Med Hyg 2000, 94:S1 90. WHO: Suggestions for the therapy of malaria. Secondth edition. Geneva: WHO Press; 2010. Anand AC, Puri P: Jaundice in malaria. J Gastroenterol Hepatol 2005, 20:1322?332. Lanca EF, Magalh s BL, Vitor-Silva S, Siqueira AM, Benzecry SG, Alexandre MA, O’Brien C, Bassat Q, Lacerda MV: Risk variables and characterization of Plamodium vivax-associated admissions to pediatric intensive care units in the Brazilian Amazon.PMID:35954127 PLoS One particular 2012, 7:e35406. Steinbrenner H, Sies H: Protection against reactive oxygen species by selenoproteins. Biochim Biophys Acta 2009, 1790:1478?485. Araujo CF, Lacerda MVG, Abdalla DSP, Lima ES: The function of platelet and plasma markers of antioxidant status and oxidative tension in thrombocytopenia amongst patients with vivax malaria. Mem Inst Oswaldo Cruz 2008, 103:517?21. Sohail M, Kaul A, Raziuddin M, Adak T: Decreased glutathione-S-tranferase activity: diagnostic and protective part in vivax malaria. Clin Biochem 2007, 40:377?82. Narsaria N, Mohanty C, Das BK, Mishra SP, Praosad R: Oxidative stress in kids with serious malaria. J Trop Pediat 2011, 58:1?. Kapoor G, Banyal HS: Glutathione reductase and thioredoxin reductase: novel antioxidant enzymes from Plasmodium berghei. Korean J Parasitol 2009, 47:421?24. Kawazu S, Yasuda-Komaki K, Oku H, Kano S: Peroxiredoxins in malaria parasites: parasitologic elements. Parasitol Int 2008, 57:1?. Dey S, Guha M, Alam A, Goyal M, Bindu S, Pal C, Maity P, Mitra K, Bandyopadhyay U: Malarial infection develops mitochondrial pathology and mitochondrial oxidative strain to market hepato.